Evaluation of Montmorillonite/Poly (L-Lactide) microcomposite spheres as ambidextrous reservoirs for controlled release of Capecitabine (Xeloda) and assessment of cell cytotoxic and oxidative stress markers

Composites Science and Technology

Volumn 90, Issue , 2014, Pages 193-201

  Kevadiya, Bhavesh D ^a,b   Chettiar, Shiva Shankaran ^c,d   Rajkumar, Shalini ^b   Bajaj, Hari C ^a   Brahmbhatt, Harshad ^a   Chaudhari, Jayesh C ^a   Thumbar, Rahul P ^c   Jhala, Devendrasinh ^d   Rao, Mandava V ^d  

^a CSIR CENTRAL SALT AND MARINE CHEMICALS RESEARCH INSTITUTE   (India)

^b NIRMA UNIVERSITY   (India)

^c VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

^d GUJARAT UNIVERSITY   (India)

Author keywords

Capecitabine (CAP); Layered structures; Nanoclays; Nanocomposites; Scanning electron microscopy (SEM); X Ray diffraction (XRD)

Indexed keywords

ANTINEOPLASTIC AGENTS; CAPECITABINE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE; HUMAN NEUROBLASTOMA; LAYERED STRUCTURES; NANO CLAYS; OXIDATIVE STRESS MARKERS;

CELL CULTURE; CHEMOTHERAPY; COMPOSITE MATERIALS; NANOCOMPOSITES; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

CYTOTOXICITY;

EID: 84890110614     PISSN: 02663538     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compscitech.2013.11.003     Document Type: Article

References (31)

1. Shoemaker L.K., Arora U., Max S.C., Lima R. 5-Fluorouracil-induced coronary vasospasm. Cancer Control 2004, 11:46-49.
2. Diasio R.B., Harris B.E. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 1989, 16:215-237.
3. Kevadiya B.D., Patel T.A., Jhala D.D., Thumbar R.P., Brahmbhatt H., Pandya M.P., et al. Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU). Eur J Pharm Biopharm 2012, 81:91-101.
4. Jin L., Liu Q., Sun Z., Ni X., Wei M. Preparation of 5-fluorouracil/β-cyclodextrin complex intercalated in layered double hydroxide and the controlled drug release properties. Ind Eng Chem Res 2010, 49:11176-11181.
5. Parker W.B. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Chem Rev 2009, 109:2880-2893.
6. Ishikawa T., Utah M., Sawada N., et al. Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol 1998, 55:1091-1097.
7. Miwa M., Ura M., Nishida M., et al. Design of a novel oral fluoropyrimidine carbamate, apecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 1998, 34:1274-1281.
8. Schuller J., Cassidy J., Dumont E., et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 2000, 45:291-297.
9. Bradford R., Hirsch S., Zafar Y. Capecitabine in the management of colorectal cancer. Cancer Manag Res 2011, 3:79-89.
10. Koukourakis G.V., Zacharias G., Tsalafoutas J., Theodoridis D., Kouloulias V. Capecitabine for locally advanced and metastatic colorectal cancer: a review. World J Gastrointest Oncol 2010, 15:311-321.
11. WalkoC M., Lindley C. Capecitabine: a review. Clin Ther 2005, 27:23-44.
12. Park J.K., Choy Y.B., Oh J.M., Kim J.Y., Hwang S.J., Choy J.H. Controlled release of donepezil intercalated in smectite clays. Int J Pharma 2008, 359:198-204.
13. Sun B., Ranganathan B., Feng S.S. Multifunctional poly (D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 2008, 29:475-486.
14. Dong Y., Feng S.S. Poly (D,L -lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005, 26:6068-6076.
15. Feng S.S., Lin M., Anitha P., Gan C.W., Zhou W. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 2009, 30:3297-3306.
16. Kevadiya B.D., Joshi G.V., Bajaj H.C. Layered bionanocomposites as carrier for procainamide. Int J Pharma 2010, 388:280-286.
17. Joshi G.V., Kevadiya B.D., Mody H.M., Bajaj H.C. Confinement and controlled release of quinine on chitosan-montmorillonite bionanocomposites. J Polym Sci Part A: Polym Chem 2012, 50:423-430.
18. Joshi G.V., Kevadiya B.D., Bajaj H.C. Design and evaluation of controlled drug delivery system of buspirone using inorganic layered clay mineral. Micropor Mesopor Mater 2010, 132:526-530.
19. Karin S., Christer L. A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells. BMC Cancer 2003, 3:1471-1480.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
21. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
22. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophysics 1984, 4:130-132.
23. Sedlak J., Lindsay R.H. Estimation of total protein-bound and non-protein sulphydryl groups in tissue with Ellman's reagent. Anal Biochem 1968, 25:192-205.
24. Levine R.L., Wehr N., Williams J.A., Stadtman E.R., Shacter E. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol 2000, 99:15-24.
25. Pani Kumar A.D., Venkata Raju Y., Sunitha G., Rama Krishna K., Ceema M., Venkateshwara Rao A. Development of validated stability indicating RP-HPLC Method for the estimation of capecitabine in pure and pharmaceutical formulations. Int J Res Pharma Biomed Sci 2011, 2:175-181.
26. Meloun M., Ferencikova Z., Vrana A. Determination of the thermodynamic dissociation constant of capecitabine using spectrophotometric and potentiometric titration data. J Chem Thermodyn 2011, 43:930-937.
27. Agnihotri S.A., Aminabhavi T.M. Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine. Int J Pharma 2006, 324:103-115.
28. Wolf M.B., Baynes J.W. The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction. Biochim Biophys Acta 2006, 1760:267-271.
29. Alexandre J., Nicco C., Chereau C., Alexis, Laurent, Weill B., et al. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 2006, 98:236-244.
30. Conklin K.A. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Therapies 2004, 3:294-300.
31. Sun Y., Huang L., Gerardo Mackenzie G., Rigas B. Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agents. J Pharmacol Exper Therapy 2011, 338:775-783.